Professional Documents
Culture Documents
Begin?
Old Ideas Revisited with New Technology
A Primer of Schizophrenia
• Occurs in approx. 1% of the population
• Mean age of onset is early 20s
• Symptoms develop years prior
• Defined by psychosis & cognitive symptoms
• Antipsychotics only effective in 40%~ cases
• No specific treatment for cognitive symptoms
• Cognitive symptoms cause long-term disability
• Causes unknown:
>1000 associative gene variants
“Electricity makes you float”
>Genetic parsing suggestive of biological subtypes Karen Blair, Artist living w/ Schizophrenia
Mental Disorders Schizophrenia The Problem New Tech->New Solutions
Häfner et al.(2017)
Introduction Project Results Conclusion
↑Ventricular
↑Cerebellar
Enlargement
Atrophy (10%)
Mesocorticolimbic
Dopaminergic Function ↑HPA Axis
Reactivity
Nigrostriatal
Dopaminergic Function
Mental Disorders Schizophrenia The Problem New Tech->New Solutions
Symptoms Emerge
Kesby et al. (2013) Catts et al. (2013)
Mental Disorders Schizophrenia The Problem New Tech->New Solutions
iPSCs
Intrinsic
Limited Disease Exogenous Endogenous
Modelling Cell-Specific Data Developmantal
Programming
Scz
Schizophrenia Risk
Schizophrenia Risk
onset onset
risk
mitigation
Acknowledgements
☺ Colak Lab ☺
Dr. Dilek Colak
Dr. Megan Allen
Nicole Volk
Nicole Sayles (fmr rotation)
Collaboration
Dr. David Greening (bioinformatics)
La Trobe Institute of Molecular Science
Infrastructure:
Center for Neurogenetics, BMRI,
WCMC Flow Cytometry Core, WCMC Proteomics Core
Funding Source:
National Health & Medical Research Council